Full Text
The Full Text of this article is available as a PDF (147.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Brand F. N., Smith R. T., Brand P. A. Effect of economic barriers to medical care on patients' noncompliance. Public Health Rep. 1977 Jan-Feb;92(1):72–78. [PMC free article] [PubMed] [Google Scholar]
- Brand F. N., Smith R. T., Brand P. A. Effect of economic barriers to medical care on patients' noncompliance. Public Health Rep. 1977 Jan-Feb;92(1):72–78. [PMC free article] [PubMed] [Google Scholar]
- Caro J. J., Salas M., Speckman J. L., Raggio G., Jackson J. D. Persistence with treatment for hypertension in actual practice. CMAJ. 1999 Jan 12;160(1):31–37. [PMC free article] [PubMed] [Google Scholar]
- Caro J. J., Speckman J. L., Salas M., Raggio G., Jackson J. D. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ. 1999 Jan 12;160(1):41–46. [PMC free article] [PubMed] [Google Scholar]
- Caro J. J., Speckman J. L., Salas M., Raggio G., Jackson J. D. Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data. CMAJ. 1999 Jan 12;160(1):41–46. [PMC free article] [PubMed] [Google Scholar]
- Clark W. F., Churchill D. N., Forwell L., Macdonald G., Foster S. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy. CMAJ. 2000 Jan 25;162(2):195–198. [PMC free article] [PubMed] [Google Scholar]
- Clark W. F., Churchill D. N., Forwell L., Macdonald G., Foster S. To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy. CMAJ. 2000 Jan 25;162(2):195–198. [PMC free article] [PubMed] [Google Scholar]
- Eraker S. A., Kirscht J. P., Becker M. H. Understanding and improving patient compliance. Ann Intern Med. 1984 Feb;100(2):258–268. doi: 10.7326/0003-4819-100-2-258. [DOI] [PubMed] [Google Scholar]
- Gibaldi M. Failure to comply: a therapeutic dilemma and the bane of clinical trials. J Clin Pharmacol. 1996 Aug;36(8):674–682. doi: 10.1002/j.1552-4604.1996.tb04235.x. [DOI] [PubMed] [Google Scholar]
- Leibowitz A., Manning W. G., Newhouse J. P. The demand for prescription drugs as a function of cost-sharing. Soc Sci Med. 1985;21(10):1063–1069. doi: 10.1016/0277-9536(85)90161-3. [DOI] [PubMed] [Google Scholar]
- Lewis E. J., Hunsicker L. G., Bain R. P., Rohde R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993 Nov 11;329(20):1456–1462. doi: 10.1056/NEJM199311113292004. [DOI] [PubMed] [Google Scholar]
- Lewis E. J., Hunsicker L. G., Bain R. P., Rohde R. D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med. 1993 Nov 11;329(20):1456–1462. doi: 10.1056/NEJM199311113292004. [DOI] [PubMed] [Google Scholar]
- McKenney J. M., Munroe W. P., Wright J. T., Jr Impact of an electronic medication compliance aid on long-term blood pressure control. J Clin Pharmacol. 1992 Mar;32(3):277–283. doi: 10.1002/j.1552-4604.1992.tb03837.x. [DOI] [PubMed] [Google Scholar]
- O'Brien B. The effect of patient charges on the utilisation of prescription medicines. J Health Econ. 1989 Mar;8(1):109–132. doi: 10.1016/0167-6296(89)90011-8. [DOI] [PubMed] [Google Scholar]
- Sibbald B. Despite some opposition, BC pharmacists to dispense morning-after pill without prescription. CMAJ. 2000 Mar 21;162(6):876–877. [PMC free article] [PubMed] [Google Scholar]